FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

3665411000001102: Pramipexole dihydrochloride monohydrate (substance)


    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2017. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    14640501000001119 Pramipexole dihydrochloride monohydrate (substance) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
    14640601000001115 Pramipexole dihydrochloride monohydrate en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Pramipexole dihydrochloride monohydrate Is a Pramipexole false Inferred relationship Existential restriction modifier

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Pramipexole 3.15mg modified-release tablets (A A H Pharmaceuticals Ltd) Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
    Pramipexole 2.62mg modified-release tablets (A A H Pharmaceuticals Ltd) 30 tablet Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
    Pramipexole 3.15mg modified-release tablets (A A H Pharmaceuticals Ltd) 30 tablet Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
    Pramipexole 3.15mg modified-release tablets (Teva UK Ltd) Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
    Pramipexole 2.62mg modified-release tablets (Teva UK Ltd) Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
    Pramipexole 2.1mg modified-release tablets (Teva UK Ltd) Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
    Pramipexole 1.57mg modified-release tablets (Teva UK Ltd) Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
    Pramipexole 1.05mg modified-release tablets (Teva UK Ltd) Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
    Pramipexole 520microgram modified-release tablets (Teva UK Ltd) Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
    Pramipexole 260microgram modified-release tablets (Teva UK Ltd) Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
    Pramipexole 3.15mg modified-release tablets (Teva UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
    Pramipexole 2.62mg modified-release tablets (Teva UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
    Pramipexole 2.1mg modified-release tablets (Teva UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
    Pramipexole 1.57mg modified-release tablets (Teva UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
    Pramipexole 1.05mg modified-release tablets (Teva UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
    Pramipexole 520microgram modified-release tablets (Teva UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
    Pramipexole 260microgram modified-release tablets (Teva UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
    Pramipexole 180microgram tablets (Sigma Pharmaceuticals Plc) 30 tablet Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
    Mirapexin 0.52mg modified-release tablets (Waymade Healthcare Plc) 10 tablet Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
    Pramipexole 700microgram tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
    Pramipexole 180microgram tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
    Pramipexole 350microgram tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
    Pramipexole 700microgram tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
    Pramipexole 180microgram tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
    Pramipexole 350microgram tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
    Oprymea 3.15mg modified-release tablets (Krka UK Ltd) Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
    Oprymea 2.62mg modified-release tablets (Krka UK Ltd) Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
    Oprymea 3.15mg modified-release tablets (Krka UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
    Oprymea 2.62mg modified-release tablets (Krka UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
    Pipexus 1.05mg modified-release tablets (Ethypharm UK Ltd) Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
    Pipexus 0.26mg modified-release tablets (Ethypharm UK Ltd) Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
    Pipexus 0.52mg modified-release tablets (Ethypharm UK Ltd) Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
    Pipexus 1.57mg modified-release tablets (Ethypharm UK Ltd) Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
    Pipexus 2.1mg modified-release tablets (Ethypharm UK Ltd) Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
    Pipexus 2.62mg modified-release tablets (Ethypharm UK Ltd) Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
    Pipexus 3.15mg modified-release tablets (Ethypharm UK Ltd) Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
    Pipexus 1.05mg modified-release tablets (Ethypharm UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
    Pipexus 0.26mg modified-release tablets (Ethypharm UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
    Pipexus 0.52mg modified-release tablets (Ethypharm UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
    Pipexus 1.57mg modified-release tablets (Ethypharm UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
    Pipexus 2.1mg modified-release tablets (Ethypharm UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
    Pipexus 2.62mg modified-release tablets (Ethypharm UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier
    Pipexus 3.15mg modified-release tablets (Ethypharm UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient False Pramipexole dihydrochloride monohydrate Inferred relationship Existential restriction modifier

    Start Previous Page 5 of 5


    This concept is not in any reference sets

    Back to Start